This article is a correction to:
Network Crosstalk as a Basis for Drug Repurposing
Dimitri Guala
Erik L. L. Sonnhammer- 1Department of Biochemistry and Biophysics, Stockholm University, Science for Life Laboratory, Solna, Sweden
- 2Merck AB, Solna, Sweden
A Corrigendum on
Network Crosstalk as a Basis for Drug Repurposing
by Guala, D., and Sonnhammer, E. L. L. (2022). Frontiers in Genetics, 13, 259. doi: 10.3389/fgene.2022.792090
In the original article, there were error. The Data Availability Statement omitted the location of the code and its implementation.
A correction has been made to Data Availability Statement
We used R (r-project.org) version 3.6.3 for statistical tests and data visualization as well as Python (python.org). The datasets generated for this study together with corresponding code can be found in the Sonnhammer group repository https://bitbucket.org/sonnhammergroup/drugrepurposingbench/.
A correction has also been made to the conflict of interest statement to declare a commercial affiliation:
Author DG was employed by company Merck AB, Sweden.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: drug repurposing, drug repositioning, network-based, benchmark, functional association network, network crosstalk, shortest path
Citation: Guala D and Sonnhammer ELL (2022) Corrigendum: Network Crosstalk as a Basis for Drug Repurposing. Front. Genet. 13:921286. doi: 10.3389/fgene.2022.921286
Received: 15 April 2022; Accepted: 19 April 2022;
Published: 16 May 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Guala and Sonnhammer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Erik L. L. Sonnhammer, Erik.Sonnhammer@dbb.su.se